EP4640213A1 — Oral pharmaceutical preparation comprising sodium-glucose cotransporter-2 inhibitor and angiotensin ii receptor blocker

USPTO Abstract

The present invention relates to an oral pharmaceutical preparation comprising a sodium-glucose cotransporter-2 inhibitor and an angiotensin II receptor blocker, which enables the sodium-glucose cotransporter-2 inhibitor and the angiotensin II receptor blocker, which have conventionally been taken separately, to be manufactured into a single combination that can be orally administered, and can be implemented in a relatively small size, thereby improving convenience of administration and patient compliance, and since there are no drug-drug interaction issues, the present invention can be effectively utilized in patients who need to take the medication for a long period of time, such as type 2 diabetes, hypertension, hypertension with diabetes, and heart failure.